Silencing of PD-1 combined with EBV-specific killer T cells for the treatment of EBV-associated B lymphoma

Silencing of PD-1 combined with EBV-specific killer T cells for the treatment of EBV-associated B lymphoma

Epstein-Barr Virus (EBV) infection is closely associated with the development of lymphoma, as it plays a significant role in the malignant transformation of lymphocytes. The expression of programmed death-1 (PD-1), which binds to PD-L1 in tumor cells, can lead to immune evasion by lymphoma cells and...

Full description

Bibliographic Details
Main Authors: Jiaping Wang, Zhijuan Xu, Yanli Lai, Yanli Zhang, Ping Zhang, Qitian Mu, Shujun Yang, Yongcheng Sun, Lixia Sheng, Guifang Ouyang
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Translational Oncology
Subjects:
Epstein-Barr virus
Apoptosis
Immune escape
Cancer immunotherapy
B lymphoma
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323002176

Internet

http://www.sciencedirect.com/science/article/pii/S1936523323002176

Similar Items